about
Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of cancer and liver diseases. Its initial focus is on the development of small-molecule inhibitors of gale...
Read More
3.59
-0.18
(-4.77%)
7,563
XNAS Volume
XNAS 29 Jul, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Galecto Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..